method

TW202633664APending Publication Date: 2026-08-16SANIA RX LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114143349
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-11-05
Filing Date
2025-11-06
Publication Date
2026-08-16

Smart Images

  • Figure TWG2TA001072927_001
    Figure TWG2TA001072927_001
  • Figure TWG2TA001072927_002
    Figure TWG2TA001072927_002
  • Figure TWG2TA001072927_003
    Figure TWG2TA001072927_003
Patent Text Reader

Abstract

The present disclosure relates to a chemogenetic system and method treating BMD using a gene therapy vector to deliver a therapeutic payload to specific cells (LUT neurons). Overexpression of the payload increases the sensitivity of the cells to an activator, thereby enabling lower doses of activator drugs to be administered. The disclosure also relates to vectors to deliver a nucleotide sequence to the target cells to enable overexpression thereof.
Need to check novelty before this filing date? Find Prior Art